glp 1 agonist drugs mechanism of action glp-1_analogs [TUSOM The Impact of GLP-1 Receptor
Description
It could thus be assumed that in a state of high cardiovascular risk, the body tries to limit disease progression by increasing the secretion of the protective agent GLP-1
Among the most promising developments in this field are GLP-1 medications, such as semaglutide and liraglutide
Benefits were attributed to weight loss, reduced inflammation, and improved myocardial metabolism [11]
Ryan et al
All three medications reduce triglycerides, but retatrutide produces the largest reductions, likely because of the glucagon-driven increase in fat oxidation
